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Table 30.1. Assessment criteria for biological effects measurements. Values are given for both 
background assessment criteria (BAC) and environmental assessment criteria (EAC), as available 
BIOLOGICAL EFFECT APPLICABLE TO: BAC EAC 
Vtg in plasma; µg ml–1 Cod 0.23  
Flounder 0.13  
Reproduction in eelpout; mean 
frequency (%) 
Malformed larvae 1  
Late dead larvae 2  
Growth-retarded larvae 4  
Frequency of broods with 
malformed larvae 
5  
Frequency of broods with 
late dead larvae 
5  
EROD; pmol mg–1 protein 
pmol min–1 mg–1 protein S9 
*pmol min–1 mg–1 microsomal 
protein 
Dab (F) 178  
Dab (M) 147  
Dab (M/F) 680*  
Flounder (M) 24  
Plaice (M) 9.5  
Cod (M/F) 145*  
Plaice (M/F) 255*  
Four spotted megrim (M/F) 13*  
Dragonet (M/F) 202*  
Red mullet (M) 208  
PAHs bile metabolites; 
 
*1-OH pyrene 
**1-OH phenanthrene 
Dab 16 ng ml–1; HPLC-F*  
3.7 ng ml–1; HPLC-F**  
0.15 pyrene-type µg ml–
1; synchronous scan 
fluorescence 
341/383 nm 
22 pyrene-type µg ml–1; 
synchronous scan 
fluorescence 341/383 nm 
Cod 21 ng ml–1; HPLC-F* 483 ng g–1 GC-MS* 
2.7 ng ml–1; HPLC-F** 528 ng g–1 GC-MS** 
1.1 pyrene-type µg ml–1; 
synchronous scan 
fluorescence 
341/383 nm 
35 pyrene-type µg ml–1; 
synchronous scan 
fluorescence 341/383 nm 
Flounder 16 ng ml–1; HPLC-F*  
3.7 ng ml–1; HPLC-F**  
1.3 pyrene-type µg ml–1; 
synchronous scan 
fluorescence 
341/383 nm 
29 pyrene-type µg ml–1; 
synchronous scan 
fluorescence 341/383 nm 
Haddock 13 ng ml–1; HPLC-F*  
0.8 ng ml–1; HPLC-F**  
1.9 pyrene-type µg ml–1; 
synchronous scan 
fluorescence 
341/383 nm 
35 pyrene-type µg ml–1; 
synchronous scan 
fluorescence 341/383 nm 
DR-Luc; ng TEQ kg–1 dry wt, Sediment (extracts) 10 40 
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silica clean-up 
DNA adducts; nm adducts mol 
DNA 
Dab 1 6 
Flounder 1 6 
Cod 1.6 6 
Haddock 3.0 6 
Bioassays; % mortality Sediment, Corophium 30 60 
Sediment, Arenicola 10 50 
Water, copepod  10 50 
Bioassays; % abnormality Water, oyster, and mussel 
embryo 
20 50 
Water, sea urchin embryo 10 50 
Bioassay; % growth Water, sea urchin embryo 30 50 
Lysosomal stability; min Cytochemical; all species 20 10 
Neutral red retention: all 
species 
120 50 
Micronuclei; 0/00 (frequency 
of micronucleated cells) 
*Gill cells 
**Haemocytes 
+Erythrocytes 
Mytilus edulis  2.5*  
2.5**  
Mytilus galloprovincialis 3.9**  
Mytilus trossulus 4.5**  
Flounder 0.0-0.3+  
Dab 0.5+  
Zoarces viviparus 0.3-0.4+  
Cod 0.4+  
Red mullet 0.3+  
Comet assay; % DNA tail Mytilus edulis 10  
Dab 5  
Cod 5  
Stress on stress; days Mytilus sp. 10 5 
AChE activity; nmol min–1 mg–1 
protein 
1Gills 
2Muscle tissue 
3Brain tissue 
*French Atlantic waters 
**Portuguese Atlantic waters 
+French Mediterranean Waters 
++Spanish Mediterranean 
Waters 
Mytilus edulis 301* 211* 
261** 191** 
Mytilus galloprovincialis 291+ 201+ 
151++ 101++ 
Flounder 2352* 1652* 
Dab 1502* 1052* 
Red mullet 1552+ 1092+ 
753++ 523++ 
Externally visible diseases*** 
Ep,Ly,Ul 
Ep,Ly,Ul 
Ac,Ep,Fi,Hp,Le,Ly,St,Ul,Xc 
Ac,Ep,Fi,Hp,Le,Ly,St,Ul,Xc 
Ac,Ep,Hp,Le,Ly,St,Ul,Xc 
Ac,Ep,Hp,Le,Ly,St,Ul,Xc 
Italics: ungraded, bold: graded 
Dab FDI: 
F: 4.4, 1.8 
M:5.2, 2.2 
F: 7.0, 3.1 
M: 10.4, 4.6 
F: 6.2, 2.8 
M: 9.5, 4.3 
M: males 
F: females 
FDI: 
F: 13.9, 6.6 
M: 32.8, 17.3 
F: 17.8, 7.8 
M: 29.8, 13.3 
F: 16.0, 7.4 
M: 26.5, 12.4 
Liver histopathology-non-
specific 
Dab NA Statistically significant 
increase in mean FDI level 
in the assessment period 
compared with a prior 
observation period or 
statistically significant 
upward trend in mean FDI 
level in the assessment 
period 
Liver histopathology- Dab Mean FDI <2 Mean FDI ≥2 A value of 
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contaminant-specific FDI = 2 is, e.g. reached if 
the prevalence of liver 
tumours is 2% (e.g. one 
specimen out of a sample 
of 50 specimens is 
affected by a liver 
tumour). Levels of FDI ≥2 
can be reached if more 
fish are affected or if 
combinations of other 
toxicopathic lesions occur 
Macroscopic liver neoplasms Dab Mean FDI <2 Mean FDI ≥2 A value of 
FDI = 2 is reached if the 
prevalence of liver 
tumours (benign or 
malignant) is 2% (e.g. one 
specimen out of a sample 
of 50 specimens is 
affected by a liver 
tumour). If more fish are 
affected, the value is FDI 
>2 
Intersex in fish; % prevalence Dab 5  
Flounder    
Cod    
Red mullet    
Zoarces viviaprus    
Scope for growth Joules/h g–1 
dry wt. 
Mussel (Mytilus sp.; 
provisional, further 
validation required) 
15 5 
Hepatic metallothionein 
µg g–1 (ww) 
1Whole animal 
2Digestive gland 
3Gills 
*Differential pulse 
polarography 
Mussel edulis 0.61* 
2.02* 
0.63* 
 
Mytilus galloprovincialis 2.01* 
3.92* 
0.63* 
 
Histopathology in mussels VVbas: Cell type 
composition of digestive 
gland epithelium; µm3 µm–
3 (quantitative) 
0.12 0.18 
MLR/MET: Digestive tubule 
epithelial atrophy and 
thinning; µm µm–1 
(quantitative) 
0.7 1.6 
VVLYS and lysosomal 
enlargement; µm3 µm–3 
(quantitative) 
VvLYS 0.0002 V>0.0004 
S/VLYS: µm2 µm–3 4  
Digestive tubule epithelial 
atrophy and thinning 
(semi-quantitative) 
Stage ≤1 Stage 4 
Inflammation (semi-
quantitative) 
Stage ≤1 Stage 3 
Imposex/intersex in snails Gastropod molluscs See OSPAR adopted 
criteria 
See OSPAR adopted 
criteria 
***Assessment criteria for the assessment of the fish disease index (FDI) for externally visible diseases 
in common dab (Limanda limanda). 
Ac, Acanthochondria cornuta; Ep, epidermal hyperplasia/papilloma; Fi, acute/healing fin rot/erosion; 
Hp, hyperpigmentation; Le, Lepeophtheirus sp.; Ly, lymphocystis; St, Stephanostomum baccatum; Ul, 
acute/healing skin ulcerations; Xc, X-cell gill disease. 
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Full details of the assessment criteria and how they were derived can be found in the 
SGIMC 2010, SGIMC 2011, and WKIMON 2009 reports on the ICES website and in 
the OSPAR background documents for individual biological effects methods. 
Data for biomarkers in some northern fish species have been obtained through the 
IRIS BioSea JIP programme (funded by Total E and P Norge and EniNorge) and the 
Biomarker Bridges programme (funded by Research Council of Norway) and have 
been used to develop EAC and BAC values for Arctic fish. 
